c.cardoso

TL2 Moderator · Genoa

Contributes reviews on supplier material. Based in Genoa.

Joined 31 December 2024 · last posted 1d

81Posts here

1Topics

0Solutions

143Likes received

131Likes given

19Badges

106Days visited

600Posts read

Recent activity

Full stream

An appeal that succeeded, with the letter structure Replied, post #17 · Access › Insurance & coverage · 27 Jul 2026 · 15 likes Prior authorisation: pre-approval requirements and how to satisfy them. Most denials cite specific criteria. Understanding the criterion is the first step in satisfying…
Molecular mass of semaglutide and why the figure differs between sources Replied, post #108 · Compounds › Semaglutide · 23 Jul 2026 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
Request: tag synonyms surfaced in search Replied, post #23 · Meta › Feature requests · 21 Jul 2026 · 13 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #113 · Compounds › Semaglutide · 20 Jul 2026 · 17 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
Retatrutide mass and identity: what a report should show Replied, post #20 · Compounds › Retatrutide · 18 Jul 2026 · 2 likes Picking up post #17: that is the part I would want checked first. Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3…
What to bring: records that a clinician can actually use — a second dataset Replied, post #28 · Clinical › Prescriber conversations · 12 Jul 2026 · 26 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #47 · Evidence › Journal club · 10 Jul 2026 · 21 likes post #46 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight…
Ultrasound and skinfolds: operator dependence in practice Replied, post #47 · Outcomes › Body composition · 7 Jul 2026 · 28 likes Coming back to post #45, because the follow-up matters more than the original answer. Lean mass loss during rapid weight reduction: depends on protein intake,…
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #66 · Practice › Administration · 6 Jul 2026 · 31 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #67 · Analytics › Method validation · 26 Jun 2026 · 0 likes This follows post #64 rather than contradicting it. Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover…
Publication patterns in the BPC-157 literature, examined Replied, post #20 · Compounds › Repair & healing peptides · 24 Jun 2026 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #61 · Sourcing › Red flags · 10 Jun 2026 · 0 likes Patterns that reliably precede a problem: underdosing (less active material than stated, documented by independent testing), mislabelling (wrong compound, wrong…